Konovo Achieves Significant Milestone in Connecting Patient and Healthcare Provider Insights with Rare Patient Voice Acquisition

Rare Patient Voice’s 200,000+ registered patients and caregivers expand Konovo’s ability to deliver connected insights across a broad range of therapeutic and geographic areas, particularly in rare and complex conditions

WATERTOWN, Mass.--(BUSINESS WIRE)--Konovo, a technology-first healthcare intelligence company, today announced it has acquired Rare Patient Voice (“RPV”), a patient recruitment company with over 200,000 registered patients and family caregivers across rare, chronic, and complex conditions. This strategic acquisition combines RPV's deep patient relationships and proven recruitment expertise with Konovo's intelligent platform, HCP access, and global scale, enabling healthcare researchers to access hard-to-reach patient populations with speed and reliability.

This acquisition expands Konovo's ability to enable patient-centric insights across therapeutic areas, particularly in rare and complex conditions where traditional recruitment methods often fall short. By combining RPV's trusted patient communities with Konovo's platform technology, researchers gain a single solution for engaging and integrating patients and healthcare professionals at scale.

Since launching in 2013, Rare Patient Voice has built a trusted community of patients and family caregivers across nine countries, delivering authentic insights that reflect real-world experiences. Konovo will apply its platform infrastructure and global capabilities to extend RPV's reach while preserving the community-first approach that has made it successful.

"At Konovo, we're focused on solving a core research challenge: accelerating high-quality insights from critical audiences and combining them into a holistic view at scale," said Tal Rosenberg, Chief Executive Officer of Konovo. "Acquiring Rare Patient Voices strengthens our ability to deliver exactly that by bringing together authentic patient perspectives with physician insights to give researchers the complete understanding they need to make confident decisions faster."

“The combination of RPV’s community-centric approach and Konovo’s platform scale creates new opportunities for researchers to engage patient and caregiver audiences more effectively,” said Wes Michael, Founder and President of Rare Patient Voice. “Together we can unlock insights that were previously hard to reach, empowering researchers with the patient perspectives they need to inform decisions and drive innovation.”

About Konovo

Konovo is a global healthcare company on a mission to transform research through technology and connected insights. Konovo simplifies the research process, connects fragmented insights, and enhances access to healthcare audiences including physicians, patients, caregivers, and allied healthcare professionals through its intelligent platform and expert-guided solutions. Operating across the Americas, Europe, and Asia, Konovo supports market research agencies, consultancies, and life science and healthcare brands with deeper, actionable insights.

About Rare Patient Voice

Rare Patient Voice empowers patients and family caregivers to have their voices heard through participation in research including market research, health economics outcomes and real-world evidence, user experience/human factors studies, and clinical trials. The RPV community includes over 200,000 patients and caregivers across more than 1,500 diseases, both rare and non-rare, in nine countries. By fostering trusted relationships and delivering high-quality insights, RPV enables research that reflects real-world patient experiences.